|Molecular Weight||419.38 g/mol|
|Applications||Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.|
Buy Dolutegravir from Toref at best competitive price. We provide best quality reference standards of Dolutegravir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes. Every compound produced by Toref is accompanied by Certificate of Analysis. If you need different pack size / quantity, please contact us or email us at firstname.lastname@example.org.